These data are therefore consistent with the possibility that the MCP-4/MCP-1 ratio might be a biomarker for PTSD, and that this candidate diagnostic biomarker might be valid for both male and female PTSD patients. This evidence concerns the gene CCL13 and post-traumatic stress disorder.